Ginkgo Bioworks Holdings (DNA) Revenue (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Revenue data on file, last reported at $19.5 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 49.06% year-over-year to $19.5 million; the trailing twelve-month figure through Mar 2026 stood at $141.3 million (down 37.84% YoY), and the FY2025 full-year result was $170.2 million, down 25.06% from the prior year.
• Revenue for Q1 2026 stood at $19.5 million, down from $33.4 million in the prior quarter.
• Across five years, Revenue topped out at $168.4 million in Q1 2022 and bottomed at $19.5 million in Q1 2026.
• The 5-year median for Revenue is $55.4 million (2023), against an average of $66.8 million.
• The widest annual swing landed in 2022, when Revenue surged 281.9%; it then plunged 64.64% in 2023.
• A 5-year view of Revenue shows it stood at $98.3 million in 2022, then slumped by 64.64% to $34.8 million in 2023, then grew by 26.16% to $43.8 million in 2024, then dropped by 23.84% to $33.4 million in 2025, then plunged by 41.69% to $19.5 million in 2026.
• The last three Revenue figures came in at $19.5 million (Q1 2026), $33.4 million (Q4 2025), and $38.8 million (Q3 2025), per Business Quant data.

Peer Comparison